Otonomy Reports Second Quarter 2017 Financial Results and Provides Corporate Update

Back to Jobs

Conference call and webcast today at 4:30 p.m. EDT SAN DIEGO , Aug. 03, 2017 (GLOBE NEWSWIRE) — Otonomy , Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, today reported financial

Apply Now